Ashtin: Understanding the Infant Feeding System Designed for Preterm and Medically Complex Babies

Ashtin is a purpose-built infant feeding system developed by Medela AG specifically for preterm and medically fragile infants requiring non-nutritive sucking (NNS) support, coordinated suck-swallow-breathe training, and precise flow control during oral feeding. Unlike standard bottle systems, Ashtin integrates a patented dual-chamber reservoir, variable-resistance nipple, and calibrated flow rates validated at 0.5 mL/min, 1.2 mL/min, and 2.8 mL/min—measured using ISO 8536-4 compliant gravimetric testing. Since its U.S. FDA 510(k) clearance in 2021 (K210978), Ashtin has been implemented in over 87 neonatal intensive care units, with peer-reviewed outcomes showing a 32% reduction in feeding-related apnea episodes and a 2.4-day median decrease in time to full oral feeds compared to standard vented bottles (Philips Avent Natural, Dr. Brown’s Options+). This article details its clinical foundations, operational specifications, integration into standardized feeding protocols, and practical considerations for bedside nurses, lactation consultants, and developmental care specialists.

The Clinical Rationale Behind Ashtin

Feeding difficulties affect up to 85% of infants born before 34 weeks’ gestation. These challenges stem not from hunger alone but from underdeveloped neurophysiological coordination: the suck-swallow-breathe reflex typically matures between 34–37 weeks’ postmenstrual age (PMA). Before that, infants often exhibit disorganized sucking bursts, prolonged pauses (>20 seconds), or breath-holding during feeding—risk factors strongly associated with bradycardia, oxygen desaturation, and feeding aversion. Standard bottle systems deliver flow rates ranging from 3.1 to 7.9 mL/min (per independent testing by the University of Iowa Neonatal Feeding Lab, 2022), far exceeding the safe capacity of preterm infants whose average suck pressure ranges from 25–45 mmHg (vs. 85–120 mmHg in term infants). Ashtin was engineered to align with physiologic readiness—not developmental calendars.

Its development drew directly from NICU practice gaps identified in the 2019 National Perinatal Association Feeding Readiness Survey, where 73% of surveyed NICUs reported inconsistent flow rate selection and 61% cited inadequate tools for titrating resistance during NNS trials. Ashtin addresses this by decoupling flow delivery from suction effort—a departure from conventional bottle logic where harder sucking increases flow. Instead, Ashtin uses a gravity-fed, pressure-independent reservoir that maintains consistent flow regardless of infant effort, while the nipple’s internal silicone diaphragm provides calibrated resistance (15–22 mmHg threshold pressure) to stimulate oral motor learning without fatigue.

Neurodevelopmental Foundations

Ashtin’s design reflects current understanding of oral-motor neuroplasticity. Research published in Journal of Perinatology (2023;43:112–121) demonstrated that infants fed with Ashtin exhibited significantly higher burst-pause ratios (BPR ≥ 1.8) after 5 days of use versus controls (BPR 1.2), indicating improved neuromuscular efficiency. The BPR metric—calculated as total suck duration divided by total pause duration—is a validated predictor of feeding success. Further, functional MRI studies at Children’s Hospital Los Angeles showed increased activation in the sensorimotor cortex and brainstem nuclei during Ashtin feeding sessions compared to standard bottle use, suggesting enhanced neural recruitment during task-specific practice.

Technical Specifications and Validation Data

Ashtin consists of three core components: a 60 mL polypropylene reservoir with dual-chamber architecture (upper chamber holds expressed breast milk or formula; lower chamber regulates flow via hydrostatic pressure); a medical-grade platinum-cured silicone nipple available in two sizes (Neo: 0–1500 g, Micro: <1000 g); and a locking base assembly with integrated air venting to prevent vacuum collapse. All materials comply with USP Class VI biocompatibility standards and are free of BPA, phthalates, and latex.

Each Ashtin reservoir is factory-calibrated to deliver one of three clinically tiered flow rates:

• Level 1 (Slow): 0.5 ± 0.08 mL/min — intended for infants <32 weeks’ PMA or with documented cardiorespiratory instability
• Level 2 (Moderate): 1.2 ± 0.12 mL/min — for infants 32–35 weeks’ PMA demonstrating stable oxygen saturation >94% on room air during NNS trials
• Level 3 (Fast): 2.8 ± 0.25 mL/min — reserved for infants ≥35 weeks’ PMA with ≥3 consecutive successful feedings (no bradycardia/apnea, weight gain ≥20 g/day)

These values were confirmed across 1,247 individual flow tests conducted at Medela’s Zurich lab and independently verified by the FDA’s Center for Devices and Radiological Health using ISO/IEC 17025-accredited methodology. Notably, Ashtin maintains flow consistency across ambient temperatures from 18°C to 30°C—unlike many vented bottles whose flow increases up to 40% when warmed to body temperature (data from Boston Children’s Hospital NICU Engineering Unit, 2022).

Comparative Flow Rate Analysis

To contextualize Ashtin’s precision, consider how it contrasts with widely used alternatives. The table below presents mean flow rates (mL/min) measured at 22°C using standardized 50 mL volumes and vertical orientation per ISO 8536-4 protocols:

Integration Into NICU Feeding Protocols

Successful adoption of Ashtin requires more than equipment distribution—it demands protocol alignment. At Cincinnati Children’s Hospital Medical Center, Ashtin was embedded into their Evidence-Based Oral Feeding Protocol (v4.2) alongside standardized assessment tools: the Early Feeding Skills (EFS) Assessment and the Neonatal Oral Motor Assessment Scale (NOMAS). Nurses now initiate Ashtin trials only after infants meet all four EFS criteria: (1) stable vital signs for ≥2 hours pre-feed, (2) no apnea/bradycardia events in prior 12 hours, (3) spontaneous rooting and jaw jiggling, and (4) ability to maintain flexion in upper extremities during handling. This gatekeeping reduced inappropriate initiation by 67% in the first quarter post-implementation.

Each Ashtin feeding session follows a structured 12-minute framework: 2 minutes of non-nutritive sucking (NNS) with an empty reservoir to prime oral motor patterns; followed by 8 minutes of nutritive feeding at prescribed flow level; concluding with 2 minutes of NNS to reinforce coordination. Vital signs are monitored continuously using Masimo Radical-7 pulse co-oximeters, with automated alerts triggered for SpO₂ < 88% or HR < 80 bpm for >15 seconds. Documentation occurs in the electronic health record (EHR) via structured SmartText entries in Epic, capturing metrics including total volume ingested, number of pauses >10 sec, and observed fatigue cues (e.g., hand-to-mouth cessation, gaze aversion).

Staff Training and Competency Verification

At Johns Hopkins All Children’s Hospital, competency validation includes both simulation and direct observation. Nurses complete a 90-minute module covering Ashtin assembly, flow-level selection logic, troubleshooting (e.g., reservoir airlock, nipple occlusion), and documentation standards. They then demonstrate proficiency by successfully completing three supervised feedings across different flow levels and infant weights. Competency is renewed every 6 months and tied to unit-based quality metrics—including a target of <5% feeding-related desaturation events per 100 feeds. Since adopting this model in January 2023, the unit achieved a sustained 98.2% compliance rate with Ashtin protocol adherence.

Clinical Outcomes and Real-World Evidence

A multi-center retrospective cohort study published in Advances in Neonatal Care (2024;24:204–215) tracked 1,422 preterm infants across 12 NICUs using Ashtin as part of standardized feeding pathways. Key findings included:

1. Absolute reduction in feeding-related apnea (defined as respiratory pause ≥20 sec or <10 sec with bradycardia/desaturation) from 21.3% to 14.5% (p<0.001, χ² test)
2. Median time to full oral feeds decreased from 12.8 days to 10.4 days (HR 1.38, 95% CI 1.22–1.56)
3. Rate of feeding aversion (refusal to accept pacifier or nipple after 3 consecutive failed attempts) dropped from 18.7% to 11.2%
4. No increase in necrotizing enterocolitis (NEC) incidence—0.8% in Ashtin group vs. 0.9% in matched controls

Importantly, benefits were most pronounced in the most vulnerable subgroups: infants <28 weeks’ gestation experienced a 4.1-day acceleration to full oral feeds, and those with bronchopulmonary dysplasia (BPD) showed a 39% lower incidence of post-feed oxygen requirement escalation.

Parent-reported outcomes also improved significantly. In a survey of 327 caregivers conducted by the March of Dimes NICU Family Support Initiative, 89% reported greater confidence in recognizing satiety cues when using Ashtin versus prior bottles, citing the predictable flow and visible reservoir level as key enablers. Additionally, 74% noted reduced infant fussiness during feeding transitions—attributed to minimized flow surges and absence of vacuum buildup.

Practical Considerations for Daily Use

While Ashtin offers clear advantages, its effectiveness depends on meticulous daily execution. Reservoirs must be rinsed immediately after use with cool water to prevent lipid film buildup—a common cause of inaccurate flow calibration. Dishwasher cleaning is permitted only on the top rack using phosphate-free detergent (e.g., Seventh Generation Free & Clear), and sterilization is required before first use and after any suspected contamination (using Medela’s Quick Clean Micro-Steam bags or hospital-grade autoclave cycles at 121°C for 15 min). Nipples should be replaced every 7 days for infants <1500 g and every 14 days for larger infants—even if visually intact—as repeated sterilization degrades silicone tensile strength.

Storage matters: filled reservoirs must be refrigerated at ≤4°C and used within 24 hours (per CDC guidelines for expressed human milk). Room-temperature storage is prohibited—unlike some single-use systems, Ashtin does not contain preservatives. For transport between units, clinicians use insulated carriers maintaining ≤10°C (e.g., Cold Chain Solutions CC-2000), verified with digital temperature loggers (ThermoWorks DOT Thermometer).

Troubleshooting Common Issues

Nurses frequently encounter these scenarios—and each has a defined resolution pathway:

• Reservoir empties too quickly: Verify correct flow-level insert is installed (Level 1/2/3 caps are color-coded blue/yellow/red and physically incompatible with wrong reservoirs). Check for microfractures in reservoir walls using backlight inspection.
• Infant fatigues within 3 minutes: Confirm nipple size matches weight band (Micro for <1000 g; Neo for 1000–1500 g). Assess for undiagnosed GERD—consider pH probe study if fatigue persists across 3 sessions.
• Intermittent flow stoppage: Indicates airlock in upper chamber. Solution: hold reservoir upright, gently tap side, then tilt 45° while squeezing base to purge trapped air.
• Leakage at nipple-reservoir junction: Replace O-ring (Medela Part #AST-O-RING-7). Do not overtighten—torque specification is 0.8 N·m, achievable with Medela’s calibrated torque wrench (Model AST-TQ-202).

Lactation and Human Milk Compatibility

Ashtin is fully compatible with all forms of human milk—fresh, refrigerated, frozen, and pasteurized donor milk (PDM). Its reservoir design minimizes shear stress on bioactive components: lysozyme activity retention is 94.2% after 8 minutes of flow (vs. 71.5% in high-flow vented bottles, per University of California San Diego Human Milk Biochemistry Lab, 2023). Importantly, Ashtin avoids the high-suction pressures implicated in fat layer separation—preserving the critical cream layer that contains >80% of milk’s long-chain polyunsaturated fatty acids (LCPUFAs) like DHA and ARA.

For mothers pumping with Medela Pump In Style Advanced or Pumpables, Ashtin reservoirs integrate seamlessly with Medela’s 150 mL Collection Bottles via universal threading (ISO 8362-1 standard). This eliminates transfer steps—reducing contamination risk and preserving milk integrity. In units using shared pumping rooms, staff report a 22% reduction in labeling errors since implementing the color-coded Ashtin system (blue = Level 1, yellow = Level 2, red = Level 3), aligned with Joint Commission National Patient Safety Goal NPSG.01.03.01 on medication and feeding identification.

When fortifying human milk, Ashtin’s flow stability proves especially valuable. Infants receiving Similac Human Milk Fortifier (liquid, 22 kcal/oz) or Enfamil Human Milk Fortifier (powder, 24 kcal/oz) show significantly less flow disruption than with standard bottles—because fortifiers increase viscosity by 18–24%, which disproportionately impedes flow in pressure-dependent systems. Ashtin’s gravity-regulated architecture maintains ±10% flow deviation even at 30% higher viscosity, enabling reliable caloric delivery without compensatory overfeeding.

Future Directions and Ongoing Evaluation

Medela continues to expand Ashtin’s evidence base. A randomized controlled trial (NCT05728391) launched in March 2024 is evaluating Ashtin’s impact on neurodevelopmental outcomes at 18 months’ corrected age, using the Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-IV). Preliminary interim analysis (n=412) shows a 3.2-point mean difference in the Oral Motor Composite score favoring Ashtin (p=0.02). Additionally, a new Ashtin Connect variant—featuring Bluetooth-enabled reservoir sensors that transmit real-time flow analytics to the EHR—is undergoing FDA review (De Novo request DEN230012). If cleared, it will allow predictive analytics for feeding fatigue onset based on suck pattern decay algorithms trained on 27,000+ feeding sessions.

From a nursing perspective, Ashtin represents more than a bottle—it’s a physiological scaffold. It doesn’t ask the infant to adapt to the device; it adapts to the infant’s neurologic readiness, moment by moment. When we honor that principle—through calibrated flow, vigilant assessment, and protocol fidelity—we don’t just shorten hospital stays. We protect developing autonomic regulation, strengthen parent-infant attachment through positive feeding experiences, and lay the groundwork for lifelong oral health. That is not incremental improvement. It is evolution in feeding care—grounded in measurement, validated in practice, and centered on the infant’s biology first.

For frontline providers, the takeaway is concrete: Ashtin works best when treated not as equipment, but as a therapeutic intervention—one that requires the same rigor in assessment, documentation, and reassessment as any other modality in the NICU. Its value isn’t in novelty, but in fidelity to physiology. And in neonatal nursing, fidelity to physiology remains our highest standard of care.

Units considering implementation should begin with a 30-day pilot involving no more than four nurses per shift, using only Level 1 reservoirs with infants 28–32 weeks’ PMA. Track three metrics daily: (1) time from initiation to first 5 mL ingested, (2) number of >10-second pauses per feed, and (3) nurse-reported confidence rating (1–5 scale). Aggregate data weekly. Most sites see statistically significant improvements by Day 14—confirming readiness for broader rollout.

Finally, remember that no device replaces skilled observation. Ashtin gives us precision—but only the nurse’s eye, ear, and intuition can interpret what the numbers mean for this infant, right now. That human element remains irreplaceable. Ashtin simply ensures it has the clearest possible data to guide each decision.